Brief: Orthocell Currently Conducting Clinical Trial Focussed On Treatment Of Tennis Elbow
Oct 17 (Reuters) - Orthocell Ltd OCC.AX :
* CURRENTLY CONDUCTING A CLINICAL TRIAL FOCUSSED ON
TREATMENT OF
TENNIS ELBOW
* REPORTS INCREASING TOTAL REVENUE TO A$1.77 MILLION IN Q1
FY24,
UP 71%
Source text for Eikon: ID:nASXccZVpQ
Further company coverage: OCC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orthocell
See all newsBrief: Orthocell Reports September Quarter Revenue Of A$3.6 Million
Australia's Orthocell rises as flagship product records first Thailand sales
Brief: Orthocell Says QTRLY A$3.2 Million Revenue Achieved
Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
Brief: Orthocell's First Surgical Use Of Remplir In US Department Of Defense